Solifenacin

Overview

Solifenacin (YM905 free base) is a novel muscarinic receptor antagonist with pK i s of 7.6, 6.9 and 8.0 for M 1 , M 2 and M 3 receptors, respectively.

Application

Products | Products > Disease Areas > Urogenital Cancer | Products > Disease Areas > Parkinson's Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Prostate Cancer | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Neurological Disease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > mAChR

Product Information

• Catalog No.: HY-A0034
• CAS No.: 242478-37-1
• Molecular Formula: C23H26N2O2
• Molecular Weight: 362.46
• Purity: 99.51%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 2.5 mg/mL (6.90 mM); Clear solution
• Availability: In-stock

Source

Original product source